Startups

Title Analyst, QC Bioassay

Filmore · Remote (US) · Remote

← All jobs
About Filmore

Backed by 500 Global.

About the role

The QC Analyst, Bioassay, with direction from manager, executes QC cell- and plate-based analytical methods including protein binding assays, cell-based potency assays, cell culture routine maintenance, and residual testing for DNA, Host Cell Protein (HCP), Protein A/G. The QC Analyst, Bioassay adheres to GMP compliant laboratory operations in accordance with regulatory guidelines. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Ability to effectively communicate and function in a fast-paced, highly technical environment is essential to success
  • Knowledge and experience growing and maintaining mammalian cell lines
  • Demonstrated ability to work cross-functionally and to develop and maintain strong business partner relationships. Excellent verbal and written communication skills and attention to detail
  • Thorough understanding of pharmaceutical/biotech testing
  • Proven ability to assist with conducting investigations, writing deviations and CAPAs
  • Basic technical writing and problem-solving skills required
More about this role

The QC Analyst, Bioassay, with direction from manager, executes QC cell- and plate-based analytical methods including protein binding assays, cell-based potency assays, cell culture routine maintenance, and residual testing for DNA, Host Cell Protein (HCP), Protein A/G. The QC Analyst, Bioassay adheres to GMP compliant laboratory operations in accordance with regulatory guidelines. This role generates analytical results and identifies laboratory exceptions, invalid assays, deviations, change controls and corrective and preventative actions (CAPAs). The QC Analyst, Bioassay is primarily responsible for executing routine analytical methods in support of manufacturing, and as needed supporting laboratory execution of analytical method transfers and validations.

FUJIFILM Biotechnologies is building the future of bioproduction in Holly Springs, North Carolina. By end of 2025, we’ll open North America’s largest end-to-end CDMO biopharmaceutical manufacturing facility, offering drug substance production, fill-finish, and packaging under one roof.

We’re looking for passionate, mission-driven people to help us realize this exciting vision and deliver the next vaccine, cure, or therapy. We...

Read the full posting on Filmore's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.